Related Experiment Videos
Vaginal bromocriptine--clinical and biochemical effects.
J Ginsburg1, P Hardiman, M Thomas
1Department of Endocrinology, Royal Free Hospital School of Medicine, London, UK.
Summary
Vaginal bromocriptine effectively lowers prolactin levels and restores menstrual cycles with minimal side effects. This method offers a well-tolerated alternative to oral treatment for hyperprolactinemia.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Pharmacology
Background:
- Oral bromocriptine causes significant adverse effects in over 50% of women.
- Vaginal absorption of bromocriptine is known, but long-term clinical data are lacking.
- Some patients intolerant to oral bromocriptine may tolerate vaginal administration.
Purpose of the Study:
- To assess the long-term clinical effects and efficacy of daily vaginal bromocriptine administration.
- To evaluate vaginal bromocriptine as a potential alternative treatment for hyperprolactinemia.
- To compare the side-effect profile of vaginal versus oral bromocriptine.
Main Methods:
- 36 women (31 hyperprolactinemic, 5 normoprolactinemic) received daily vaginal bromocriptine for up to 2 years.
- 17 participants were previously intolerant to oral bromocriptine.
- Serum prolactin levels, menstrual cyclicity, galactorrhea, and side effects were monitored.
Main Results:
- Bromocriptine was well absorbed from the vagina.
- 28 of 31 hyperprolactinemic women showed reduced serum prolactin levels.
- Menstrual cyclicity was restored, galactorrhea resolved, and one patient conceived; only three women reported minor side effects.
Conclusions:
- Daily vaginal bromocriptine is clinically effective for managing hyperprolactinemia.
- Vaginal administration significantly reduces adverse effects compared to oral therapy.
- Vaginal bromocriptine presents a viable first-line treatment option, particularly for patients intolerant to oral bromocriptine.